BioNTech SE (BNTX) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending September 2025, BioNTech SE (NASDAQ:BNTX) is held by 255 institutional firms.

• These investors collectively held 21.2% of the company's total shares outstanding in September 2025, down from 22.7% in June 2025.
• Quarterly data indicates a -5.17% shift in institutional share volume, and the annual owner count reflects a decrease of 13.85%.
• Of these 255 institutional investors, 94 increased their holdings in BioNTech SE, while 102 of them reduced positions, and 59 investors maintained their exposure.
• The aggregate institutional position in BioNTech SE now stands at 51.04Mn shares as of September 2025, after investors decreased their holdings (down by 2.78Mn shares quarter on quarter which is up 5.74Mn shares year over year).
• BAILLIE GIFFORD & CO continues to be the largest institutional holder of BioNTech SE as of September 30, 2025, with a position of 7.88Mn shares, representing 3.28% of the company's outstanding stock.
• Among the most significant buyers of BioNTech SE during September 2025 were DODGE & COX (2.77Mn), T. Rowe Price Investment Management, Inc. (1.24Mn), BANK OF AMERICA CORP /DE/ (444.33K), UBS Group AG (349.15K), MILLENNIUM MANAGEMENT LLC (215.93K).
• Leading sellers of BioNTech SE stock in September 2025 included FMR LLC (2.71Mn), PFIZER INC (2.00Mn), Invesco Ltd. (606.94K), BlackRock, Inc. (548.72K), Bank of New York Mellon Corp (540.01K).
• The top 10 institutional holders of BioNTech SE for the quarter ending September 2025 included BAILLIE GIFFORD & CO (7.88Mn), FMR LLC (5.45Mn), T. Rowe Price Investment Management, Inc. (4.83Mn), FLOSSBACH VON STORCH SE (4.23Mn), PRIMECAP MANAGEMENT CO/CA/ (3.87Mn), DODGE & COX (3.65Mn), PFIZER INC (1.66Mn), Temasek Holdings (Private) Ltd (1.51Mn), Capital International Investors (1.14Mn), BNP PARIBAS FINANCIAL MARKETS (1.10Mn).